Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) reached a new 52-week high on Monday . The stock traded as high as $14.35 and last traded at $14.24, with a volume of 1685319 shares trading hands. The stock had previously closed at $13.33.
Silverback Therapeutics Trading Up 6.8 %
The firm has a market capitalization of $513.47 million, a price-to-earnings ratio of -5.51 and a beta of 0.60. The firm has a 50 day moving average price of $9.91 and a two-hundred day moving average price of $9.07.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- Using the MarketBeat Dividend Yield Calculator
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- Overbought Stocks Explained: Should You Trade Them?
- 2 Option Strategies to Maximize Profits in a Bear Market
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
